PTJ
RMD icon

Paul Tudor Jones’s ResMed RMD Stock Holding History

Paul Tudor Jones’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$857K Buy
4,400
+3,000
+214% +$622K ﹤0.01% 2523
2026
Q1 		$314K Sell
1,400
-1,400
-50% -$349K ﹤0.01% 3109
2025
Q4 		$674K Sell
2,800
-700
-20% -$179K ﹤0.01% 2541
2025
Q3 		$958K Sell
3,500
-900
-20% -$246K ﹤0.01% 2302
2025
Q2 		$1.14M Buy
+4,400
New +$1.05M ﹤0.01% 2042
2025
Q1 		– Sell
-3,100
Closed -$709K – 3573
2024
Q4 		$709K Buy
+3,100
New +$746K ﹤0.01% 1981
2024
Q1 		– Sell
-11,000
Closed -$1.89M – 2699
2023
Q4 		$1.89M Sell
11,000
-27,800
-72% -$4.27M 0.02% 1124
2023
Q3 		$5.74M Buy
+38,800
New +$7.02M 0.06% 444

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Paul Tudor Jones's RMD Position: Q2 2026 in Review

Paul Tudor Jones sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,796 shares — an estimated $372K sold.

Paul Tudor Jones first reported a position in RMD in Q2 2013 and held it in 29 quarters. The position peaked at $33.9M in Q1 2024. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Paul Tudor Jones reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 1,796 ResMed shares in Q2 2026, an estimated $372K.
  • Paul Tudor Jones first reported a position in ResMed in Q2 2013 and held it in 29 quarters.
  • Paul Tudor Jones's ResMed position peaked at $33.9M in Q1 2024.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.